Unnatural Products

Unnatural Products

Private
Santa Cruz, CaliforniaHealthcare & Life Scienceshttps://www.unnaturalproducts.com

Last Round

Series B

Mar 16, 2026

Total Funding Raised

$83M

Company Overview

Unnatural Products is a biotechnology company that offers a computational biology platform for engineering peptides aimed at traditionally undruggable targets, utilizing machine learning to optimize macrocyclic compounds and expedite the drug discovery process.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

macrocyclic peptidesAI drug discoveryundruggable targetsdrug discovery platformoral peptidescomputational drug discoverycell-permeable peptidesin silico drug designhit-to-lead discoverypharma partnershipsoncology drug discoveryoral biologicscomputational biologyrare disease therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unnatural Products Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Unnatural Products Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMar 16, 2026
Series ADec 19, 2023
SeedSep 17, 2019

Key People

Founding team and executive leadership

Cameron Pye

CEO

Executive Team

Unnatural Products Investors

Notable investors and investment history

InvestorRounds
Rising Tide FundSeries A, Seed
Merck Global Health Innovation FundSeries B
Better VenturesSeries A, Seed
Blue Bear VenturesSeries A, Seed
GaingelsSeries A
Merck Global Health Innovation FundSeries B, Series A
ARTIS VenturesSeries B, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2026

    $45M round raised.

  • Feb 24, 2026

    Partnered with Novartis to develop cardiovascular therapies using AI.

Unnatural Products Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Unnatural Products Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Unnatural Products's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Cruz, California
Employee Range63
Year Founded2017
Last FundingMar 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.